Daniel Atienza

1.4k total citations
14 papers, 820 citations indexed

About

Daniel Atienza is a scholar working on Oncology, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel Atienza has authored 14 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Physiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel Atienza's work include Nutritional Studies and Diet (4 papers), Nutrition and Health in Aging (4 papers) and Cancer survivorship and care (3 papers). Daniel Atienza is often cited by papers focused on Nutritional Studies and Diet (4 papers), Nutrition and Health in Aging (4 papers) and Cancer survivorship and care (3 papers). Daniel Atienza collaborates with scholars based in United States, Canada and Australia. Daniel Atienza's co-authors include Alan Trounson, Ursula Manuelpillai, Yuben Moodley, Chrishan S. Samuel, Jorge Tchongue, Richard L. Boyd, Leonard B. Saltz, Hedy L. Kindler, Robert J. Mayer and Jeffrey A. Meyerhardt and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Daniel Atienza

14 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Atienza United States 8 278 251 243 219 177 14 820
Ching-Tien Peng Taiwan 20 163 0.6× 513 2.0× 172 0.7× 101 0.5× 24 0.1× 42 999
İlknur Kozanoğlu Türkiye 17 150 0.5× 354 1.4× 117 0.5× 63 0.3× 71 0.4× 72 787
Sang Kuon Lee South Korea 18 242 0.9× 132 0.5× 594 2.4× 108 0.5× 91 0.5× 42 878
David Bryant United States 10 386 1.4× 39 0.2× 124 0.5× 217 1.0× 117 0.7× 27 729
Na Rae Kim South Korea 15 110 0.4× 128 0.5× 148 0.6× 106 0.5× 43 0.2× 90 714
Maryna Krawczuk‐Rybak Poland 12 96 0.3× 73 0.3× 75 0.3× 149 0.7× 57 0.3× 130 770
A Werner United States 16 125 0.4× 63 0.3× 125 0.5× 99 0.5× 137 0.8× 40 664
Jae Won Choe South Korea 13 143 0.5× 40 0.2× 175 0.7× 172 0.8× 45 0.3× 24 612
Gali Epstein Shochet Israel 16 390 1.4× 55 0.2× 63 0.3× 64 0.3× 95 0.5× 41 660
W. A. Kamps Netherlands 22 154 0.6× 62 0.2× 91 0.4× 316 1.4× 80 0.5× 29 1.2k

Countries citing papers authored by Daniel Atienza

Since Specialization
Citations

This map shows the geographic impact of Daniel Atienza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Atienza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Atienza more than expected).

Fields of papers citing papers by Daniel Atienza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Atienza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Atienza. The network helps show where Daniel Atienza may publish in the future.

Co-authorship network of co-authors of Daniel Atienza

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Atienza. A scholar is included among the top collaborators of Daniel Atienza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Atienza. Daniel Atienza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lee, Seohyuk, Sui Zhang, Fang‐Shu Ou, et al.. (2022). Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance). The Oncologist. 27(6). e494–e505. 15 indexed citations
2.
Blarigan, Erin L. Van, Fang‐Shu Ou, Charles S. Fuchs, et al.. (2022). Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer. JAMA Network Open. 5(2). e220145–e220145. 6 indexed citations
3.
Cheng, En, Sui Zhang, Fang‐Shu Ou, et al.. (2020). The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance). Cancer Epidemiology Biomarkers & Prevention. 29(8). 1692–1695. 7 indexed citations
4.
Blarigan, Erin L. Van, Charles S. Fuchs, Donna Niedzwiecki, et al.. (2018). Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance). Cancer Epidemiology Biomarkers & Prevention. 27(4). 438–445. 50 indexed citations
5.
Blarigan, Erin L. Van, Charles S. Fuchs, Donna Niedzwiecki, et al.. (2018). Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis. JAMA Oncology. 4(6). 783–783. 164 indexed citations
6.
Fuchs, Charles S., Donna Niedzwiecki, Xing Ye, et al.. (2017). Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance).. Journal of Clinical Oncology. 35(4_suppl). 585–585. 4 indexed citations
7.
Fuchs, Charles S., Donna Niedzwiecki, Xing Ye, et al.. (2017). American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance).. Journal of Clinical Oncology. 35(15_suppl). 10006–10006. 2 indexed citations
8.
Fadelu, Temidayo, Donna Niedzwiecki, Sui Zhang, et al.. (2017). Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance).. Journal of Clinical Oncology. 35(15_suppl). 3517–3517. 3 indexed citations
9.
Fuchs, Michael, Kaori Sato, Donna Niedzwiecki, et al.. (2014). Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance). PLoS ONE. 9(6). e99816–e99816. 57 indexed citations
10.
Jeon, Justin Y., Kaori Sato, Donna Niedzwiecki, et al.. (2013). Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance. Clinical Colorectal Cancer. 12(4). 233–238. 30 indexed citations
11.
Moodley, Yuben, Chrishan S. Samuel, Vijesh Vaghjiani, et al.. (2010). Human Amnion Epithelial Cell Transplantation Abrogates Lung Fibrosis and Augments Repair. American Journal of Respiratory and Critical Care Medicine. 182(5). 643–651. 166 indexed citations
12.
Moodley, Yuben, Daniel Atienza, Ursula Manuelpillai, et al.. (2009). Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury. American Journal Of Pathology. 175(1). 303–313. 287 indexed citations
13.
Hutson, Thomas E., Svetislava J. Vukelja, Daniel Atienza, et al.. (2008). Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium. Investigational New Drugs. 26(2). 151–158. 4 indexed citations
14.
Atienza, Daniel, Charles L. Vogel, Bruce J. Trock, & Sandra M. Swain. (1995). Phase II study of oral etoposide for patients with advanced breast cancer. Cancer. 76(12). 2485–2490. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026